Cross-source evidence timeline

Eloralintide research timeline

Follow 20 selected, directly cited source records from November 19, 2025 through November 13, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

20Selected records
2Source years
2Evidence lanes
November 13, 2026Latest source date

Source year

2026

19 records
  1. Clinical trials

    ClinicalTrials.gov record NCT07935304↗

    PeptideScanner retained ClinicalTrials.gov record NCT07935304 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT07282600↗

    PeptideScanner retained ClinicalTrials.gov record NCT07282600 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT07353931↗

    PeptideScanner retained ClinicalTrials.gov record NCT07353931 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT07369011↗

    PeptideScanner retained ClinicalTrials.gov record NCT07369011 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT07392190↗

    PeptideScanner retained ClinicalTrials.gov record NCT07392190 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT07900633↗

    PeptideScanner retained ClinicalTrials.gov record NCT07900633 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-03, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  7. Clinical trials

    ClinicalTrials.gov record NCT07215559↗

    PeptideScanner retained ClinicalTrials.gov record NCT07215559 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-10-09, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  8. Clinical trials

    ClinicalTrials.gov record NCT07589608↗

    PeptideScanner retained ClinicalTrials.gov record NCT07589608 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  9. Clinical trials

    ClinicalTrials.gov record NCT07808060↗

    PeptideScanner retained ClinicalTrials.gov record NCT07808060 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  10. Clinical trials

    ClinicalTrials.gov record NCT07701083↗

    PeptideScanner retained ClinicalTrials.gov record NCT07701083 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  11. Clinical trials

    ClinicalTrials.gov record NCT07321886↗

    PeptideScanner retained ClinicalTrials.gov record NCT07321886 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-09-22, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  12. Clinical trials

    ClinicalTrials.gov record NCT07738614↗

    PeptideScanner retained ClinicalTrials.gov record NCT07738614 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-08-20, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  13. Clinical trials

    ClinicalTrials.gov record NCT07426380↗

    PeptideScanner retained ClinicalTrials.gov record NCT07426380 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-08-19, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  14. Literature metadata

    Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept.↗

    PubMed lists PMID 41559929 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase I, Multicenter Study, with publication-date metadata of 2026-01-20 (day precision). PeptideScanner associated the retained record with the identity slug eloralintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  15. Clinical trials

    ClinicalTrials.gov record NCT07765511↗

    PeptideScanner retained ClinicalTrials.gov record NCT07765511 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-08-14, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  16. Clinical trials

    ClinicalTrials.gov record NCT07665879↗

    PeptideScanner retained ClinicalTrials.gov record NCT07665879 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  17. Clinical trials

    ClinicalTrials.gov record NCT06230523↗

    PeptideScanner retained ClinicalTrials.gov record NCT06230523 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-06-24, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  18. Clinical trials

    ClinicalTrials.gov record NCT07401862↗

    PeptideScanner retained ClinicalTrials.gov record NCT07401862 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was eloralintide.↗

  19. Clinical trials

    ClinicalTrials.gov record NCT06916065↗

    PeptideScanner retained ClinicalTrials.gov record NCT06916065 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-01-30, and PeptideScanner's reviewed identity mapping was eloralintide.↗

Source year

2025

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT06916091↗

    PeptideScanner retained ClinicalTrials.gov record NCT06916091 at 2026-11-16T01:48:01.052Z. Its registry update date was 2025-11-19, and PeptideScanner's reviewed identity mapping was eloralintide.↗